Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenstone is a leading pharmaceutical company specializing in the distribution of authorized generic versions of brand-name medications. As a wholly-owned subsidiary of Viatris (and formerly Pfizer), the company provides patients with high-quality, FDA-approved generic drugs that are identical to the original brand-name products in terms of active ingredients, dosage form, and strength. Greenstone's extensive portfolio covers a wide range of therapeutic areas, including cardiovascular health, mental health, and infectious diseases. By leveraging the manufacturing standards of its parent organization, Greenstone ensures a reliable supply of affordable medications to the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GreenSpa.